Showing results (321-330 of 887) with videos related to
Sort By:
Pageof 89
Annals of Internal Medicine|August 23, 2012
Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysisAshish Upadhyay, Amy Earley, Jenny L Lamont, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2023
Hyponatraemia and fluid overload are associated with higher risk of mortality in dialysis patientsJule Pinter, Bernd Genser, Ulrich Moissl, et al.BMC Nephrology|March 26, 2013
Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetesAndreas Schneider, Markus P Schneider, Hubert Scharnagl, et al.Journal of the American Society of Nephrology : JASN|March 19, 2011
Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitusWiebke Fenske, Christoph Wanner, Bruno Allolio, et al.NDT Plus|January 20, 2011
The 2008 ERA-EDTA Registry Annual Report-a précisVianda S Stel, Moniek W M van de Luijtgaarden, Christoph Wanner, et al.Artificial Organs|January 8, 2014
Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysisDetlef H Krieter, Eric Devine, Christoph Wanner, et al.Kidney International|April 5, 2003
Cardiomyocyte loss in experimental renal failure: prevention by ramiprilKerstin Amann, Karin Tyralla, Marie-Luise Gross, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 28, 2002
Nutritional status in dialysis patients: a European consensusFrancesco Locatelli, Denis Fouque, Olof Heimburger, et al.American Journal of Physiology. Renal Physiology|November 6, 2003
1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized ratAlexander Kuhlmann, Christian S Haas, Marie-Luise Gross, et al.American Journal of Nephrology|August 8, 2013
Erythropoietin combined with ACE inhibitor prevents heart remodeling in 5/6 nephrectomized rats independently of blood pressure and kidney functionNadezda Gut, Grzegorz Piecha, Firas Aldebssi, et al.Pageof 89